Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BAY 3713372 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on BAY 3713372, a putative PRMT5 inhibitor (Apr 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BAY 3713372 | BAY-3713372|BAY3713372 | PRMT5 Inhibitor 21 | Limited information is currently available on BAY 3713372, a putative PRMT5 inhibitor (Apr 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06914128 | Phase I | BAY 3713372 | A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors | Recruiting | USA | SWE | NLD | ITA | GBR | ESP | DNK | CZE | BEL | AUS | 3 |